Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 23 2014
Print

Sartorius Acquires Stake in AllPure Technologies



Published April 28, 2014
Sartorius Stedim Biotech (SSB) has signed a contract to acquire majority stake in AllPure Technologies LLC, a start-up company based in New Oxford, PA that specializes in single-use components for biopharma applications. AllPure was established in 2010, and in 2013 had revenues of approximately $3 million with 25 employees. Financial terms were not disclosed.
 
Reinhard Vogt, member of SSB’s executive board said, “AllPure further completes our portfolio with innovative products that help our customers develop and manufacture their pharmaceutical drugs safer and more efficiently. I am really looking forward to working with the AllPure team and to all that we can accomplish together.”
 
“We are excited to leverage Sartorius Stedim’s impressive R&D capabilities so that we can accelerate the launch of new products from AllPure. And SSB’s global reach and industry relationships grant access to considerably more customers, especially in Europe and Asia, which have tremendous potential for AllPure’s products,” said Michael Zumbrum, president of AllPure.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On